Nektar Therapeutics (NASDAQ: NKTR) is one of the best hot stocks to buy according to Wall Street analysts. On June 24, Nektar ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Figure skater Michelle Hong used to hide her skin as much as possible due to her condition—but with effective treatment and ...

In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.

Eczema tends to worsen in cold weather. But there are plenty of steps you can take to counteract flare-ups. When you’re outside, be sure to protect your skin from cold air exposure and dress in ...

Nektar Therapeutics (NASDAQ:NKTR) announced Tuesday that its lead asset, rezpegaldesleukin, reached the main goal in a ...

Nektar’s shares have surged more than twofold after a Phase IIb study of its atopic dermatitis (AD) therapy rezpegaldesleukin ...

Doctors report a steady increase in eczema cases among infants across Indian cities. Experts warn that genetics and environmental factors are key drivers behind this troubling trend.

Nektar, which accused Lilly of making errors in its analysis of the data, forged ahead with the programme and started the ...

A team of researchers led by the University of Exeter have been awarded a £3.3 million grant by the Medical Research Council ...

Breakthrough study could lead to new treatments as experts explore how skin fungi trigger debilitating skin condition ...

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a midstage study of its eczema treatment.